Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 14/20 | 0.53 |
| ▸ | ITGA2B | P08514 | 14/20 | 0.53 |
| ▸ | MAOA | P21397 | 2/20 | 0.52 |
| ▸ | MAOB | P27338 | 2/20 | 0.52 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.51 |
| ▸ | GRM5 | P41594 | 1/20 | 0.46 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8545644 | 0.90 | ITGB3 (0.51) | ITGB3ITGA2BAOC3S1PR1 | |
| SCHEMBL8547139 | 0.85 | MAOA (0.53) | ITGB3ITGA2BMAOAMAOBAOC3 | |
| SCHEMBL8550212 | 0.84 | DRD3 (0.55) | GRM5 | |
| SCHEMBL8543792 | 0.83 | AOC3 (0.47) | ITGB3ITGA2BMAOAMAOBAOC3 | |
| Formamide SCHEMBL8543151 | 0.83 | ITGB3 (0.48) | ITGB3ITGA2BAOC3 | |
| SCHEMBL8549552 | 0.83 | AOC3 (0.54) | ITGB3ITGA2BMAOAMAOBAOC3 | |
| SCHEMBL8545172 | 0.83 | AOC3 (0.54) | ITGB3ITGA2BAOC3GRM5 | |
| SCHEMBL8549697 | 0.83 | MAOA (0.48) | ITGB3ITGA2BMAOAMAOBAOC3 | |
| SCHEMBL8543655 | 0.82 | ITGB3 (0.54) | ITGB3ITGA2BMAOAMAOBAOC3 | |
| SCHEMBL8543334 | 0.82 | ITGB3 (0.48) | ITGB3ITGA2BMAOAMAOBAOC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0526402-B1 | Heteroaryl substituted hydroxylamine derivatives as lipoxygenase inhibitors | CIBA GEIGY AG (CH) | 1998-01-21 | — | — | EP | disclosed |
| US-5350761-A | Lipoxygenase inhibitors as antiinflammatory agents and antiallergens | CIBA-GEIGY CORPORATION (US) | 1994-09-27 | — | — | US | disclosed |
| US-5334600-A | Lipoxygenase inhibitors | CIBA-GEIGY CORPORATION (US) | 1994-08-02 | — | — | US | disclosed |
| US-5260316-A | Lipoxygenase inhibitor | CIBA-GEIGY CORPORATION (US) | 1993-11-09 | — | — | US | disclosed |
| EP-0526402-A1 | Heteroaryl substituted hydroxylamine derivatives as lipoxygenase inhibitors | CIBA-GEIGY AG (CH) | 1993-02-03 | — | — | EP | disclosed |